Aztreonam avibactam vs cefiderocol is an important clinical comparison in the treatment of difficult-to-treat Gram-negative infections. Both agents have activity against selected resistant pathogens, but they work through different mechanisms and have different clinical evidence bases. Although both are used in the context of resistant infections, they work through different mechanisms and have different microbiological...Read More